Northwestern Mutual Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-325
Closed -$11.6K 3784
2024
Q1
$11.6K Buy
+325
New +$11.3K ﹤0.01% 2584
2023
Q3
Sell
-100
Closed -$3.15K 3501
2023
Q2
$3.15K Buy
+100
New +$3.11K ﹤0.01% 2898
2022
Q4
Sell
-500
Closed -$15K 3454
2022
Q3
$15K Hold
500
﹤0.01% 2333
2022
Q2
$14K Hold
500
﹤0.01% 2392
2022
Q1
$17K Sell
500
-462
-48% -$16K ﹤0.01% 2371
2021
Q4
$41K Sell
962
-1,186
-55% -$52.9K ﹤0.01% 2052
2021
Q3
$98K Buy
2,148
+136
+7% +$6.24K ﹤0.01% 1642
2021
Q2
$98K Buy
2,012
+326
+19% +$15.6K ﹤0.01% 1604
2021
Q1
$85K Buy
1,686
+1,186
+237% +$65.7K ﹤0.01% 1549
2020
Q4
$26K Hold
500
﹤0.01% 1870
2020
Q3
$21K Buy
+500
New +$20.6K ﹤0.01% 1784

Other funds holding SBIO

Northwestern Mutual Wealth Management's SBIO Position: Q2 2024 in Review

Northwestern Mutual Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2024, closing a stake of 325 shares — an estimated $11.6K sold.

Northwestern Mutual Wealth Management first reported a position in SBIO in Q3 2020 and held it in 11 quarters. The position peaked at $98K in Q3 2021. 38 funds tracked by Wall St. Rank hold SBIO as of Q2 2024.

  • Northwestern Mutual Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 325 ALPS Medical Breakthroughs ETF shares in Q2 2024, an estimated $11.6K.
  • Northwestern Mutual Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q3 2020 and held it in 11 quarters.
  • Northwestern Mutual Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $98K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.